Raju Mohan, Ventyx Biosciences CEO
Ventyx sprints to Wall Street less than a year after emerging from stealth
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
It took seven months from exiting quiet …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
